24 results
8-K
EX-99.1
RGLS
Regulus Therapeutics Inc
20 Feb 13
Regulus Reports Fourth Quarter and Year-End 2012 Financial Results and Highlights
12:00am
.
Enhanced Executive Management Team and Augmented Board of Directors. Victor Knopov, Ph.D., a recognized expert in oligonucleotide drug development
424B4
tzbdezz1p4
5 Oct 12
Prospectus supplement with pricing info
12:00am